Monday, 28 October 2013

"We would rather believe in nothingness than not believe..."

Nietzsche, “On the Genealogy of Morality”

We are fundamentally set up to know things. We have five main senses that constantly capture snapshots of the world and the billions of nerve cells in our heads are there to interpret, edit and create a seamless experience based on these sensations. Every waking moment is spent experiencing the world and ourselves; we incessantly gather information and try to make a coherent picture out of everything we experience. We must know.

However, there are limits to our knowing; the way we sense and build a world is limited (e.g. we only see the world in colour), we have an imperfect point of view (we can never experience perfection since a perfect view point requires us to experience another person's point of view, which is impossible), we are limited to experiencing the present and only know the past (the future is more or less inaccurate predictions). Therefore, when there is a barrier to understanding, instead of accepting that we may never know and living with the uncertainty, we try to fill the void with such spurious notions as God, the "afterlife", contacting the dead, assigning causes to unrelated effects (e.g. I am to blame for my Parkinson's), seeking to control things outside of our influence (e.g. praying).

We are not scared of the unknown; we are terrified of not knowing. We simply must know, even if it is knowing nothingness (or things we cannot experience such as the perfection of God). This impulse to know at all costs can make us vulnerable; the nothingness we believe often has conditions that must be fulfilled (e.g. we must believe in God otherwise we go to hell; but two nothings do not make a something!); nothingness, being nothing, must justify itself.

We should live with the uncertainty of not knowing, but instead we cram our lives full of spurious, unverified “knowledge” outside of experience; we replace the lack of certainty with the certainty of nothing…

Saturday, 26 October 2013

When do we become who we are?

“Yes, once I was a hero but
The bombs began to fall…

"Posthumous Autobiography" by Vernon Scannell (Collected Poems; Faber and Faber)

At what point in our lives do we become ourselves? When are we the hero and when the villain? Scannell, in his wonderfully ambiguous poem (a poem that refuses to offer an easy answer), suggests to me that we can claim we are all “heroes” through our imagination and by our inaction. However, by doing something we risk and are then stripped of our ideal; the world intervenes to render us vulnerable, confused and scarred by life. We reach out, in vain, for some comfort in the hero we thought we were but we see we are in a muddled, random and painful world (when “the bombs began to fall”).

However, when we do engage with the world there is a possibility,

“when the storm enraged the grunting sea
into a foaming epileptic fit,"

that we find ourselves in our reactions and the process of replacing

“the captain on the howling bridge,
staring the tumult out”

and riding “safely home”. But not as a hero, as ourselves. We are our reaction to what knocks us down in life; we are the ones who find joy in the gaps between the falling bombs; we are the person who picks themselves up and stares out the world again; we are the resolve we show and the determination we have in seeing there is always something left to do in this life. There is immense value in the process of doing just one more thing. When we stop doing this, we can then say,

“once I was alive…”

When do we become who we are? We are ourselves at every step of the process of life.

Wednesday, 23 October 2013

Losing what you never had

There was once a calmness in my body, a stillness I didn’t even realise was there; I saw through it like it was a transparent plastic sheet wrapped around me. That is what Parkinson’s takes away. It rips that sheet from you and exposes you to the awareness of what can be lost only after you have lost it.

Parkinson’s compels you to mourn something you didn’t know you had. You can’t hold it one last time and say goodbye; it’s like your wife divorcing you when you didn’t even realise you were married. Mourning such a loss can feel very strange!

Tuesday, 22 October 2013

Switching on a light to solve the puzzle - finding a Parkinson's cure PART 2

...To cells...

Understanding the symptoms and progression of Parkinson's in patients is vital. However, it can only hint at the cause at the level of cells and genes. Work has to be done at the molecular and cellular levels to work out why nerve cells are dieing and therefore what can be done to counteract this. This would form the basis of a cure.

To work on nerve cells affected by Parkinson’s in the lab requires the development of reliable cells. Amazingly, human cells can be grown outside the body in single layers on the bottom of a petri dish. Even more amazing, skin cells can be grown and then converted into nerve cells that produce dopamine. Dr Elizabeth Hartfield has successfully produced and tested nerve cells grown from Parkinson’s patient skin cells. The nerve cells are equivalent to those cells that die in Parkinson’s. This is a very impressive feat and forms an invaluable resource to understand the proteins and processes inside cells that go wrong in Parkinson’s. Studies are underway investigating alpha synuclein and mitochondria (the energy factories of the cell), both implicated as causes of nerve cell death.

As with each torch that researchers use they have advantages and disadvantages; cells grown in layers are in two dimensions whereas the nerve cells in my brain make connections in three dimensions. This connectivity likely has important consequences for how nerve cells pass messages to each other.

...To the brain...

This is where another torch comes in: studying the next level of complexity in the brain relevant to Parkinson’s, the basal ganglia. Nerve cells in the substantia nigra send out long projections from their cell surface (called axons) to activate (via dopamine) another region in the basal ganglia called the striatum. This structure is important in initiating movement. In Parkinson’s sufferers there isn’t enough dopamine to activate the striatum resulting in movement problems.

Dr Stephanie Cragg presented fascinating data showing that there is more than one route taken by substantia nigra axons to activate the striatum. After a nerve cell is stimulated by an electrical impulse, dopamine is released from the end of the axon and receptors on nerve cells that make up the striatum grab hold of dopamine. As a result an electric impulse is generated in these initial striatum nerve cells, which is subsequently passed to other nerve cells in the striatum and beyond. Dr Cragg’s team has identified new receptors on striatum nerve cells that form an access point to the alternative route. It is hoped that this newly discovered route can be used to get more dopamine to the striatum to restore movement in Parkinson’s sufferers.

...To animal models...

Again, this torch has a disadvantage; the necessary focus on the striatum misses the affect on other parts of the brain and ultimately on movement and behaviour. Luckily, the link between what happens in the brain and its affect on complex movement can be addressed in model organisms such as mouse. Dr Richard Wade-Martins demonstrated that a human gene (e.g. alpha synuclein) can be inserted into mouse DNA and the resulting mouse will express the human gene. If the gene is faulty it will form the classical movement problems of Parkinson’s. Amazing! This allows researchers to follow what is happening in substantia nigra nerve cells and the affect this has on the movement of the mouse.

Animal models of Parkinson’s form a crucial stepping stone between understanding what’s happening in Parkinson’s affected cells and the movement symptoms in Parkinson’s sufferers like me. Work in animals like mice link the other three torches to make a powerful collective beam of light.

...To patients again...

Of course, humans are not big mice so any understanding extracted from the mouse will have to be tested in humans before the puzzle is solved and a cure given.

The road to a cure is long and complicated. But each piece that is added to the Parkinson's jigsaw by researchers like those at the OPDC, the closer a cure will become.

Please support research and Dave the worm! http://www.davetheworm.org/

OPDC http://opdc.medsci.ox.ac.uk/

Monday, 21 October 2013

Switching on a light to solve the puzzle - finding a Parkinson's cure PART 1

Imagine you are in a windowless room that is plunged in darkness and the task facing you is to complete a giant jigsaw puzzle; the puzzle, once completed, will form a cure for Parkinson's. It's a fiendish puzzle too because not all the pieces will fit and the final picture will change as you put pieces together. It is highly unlikely you will finish it by groping in the dark and randomly putting the jigsaw together; indeed you won't even know when you have finished if you can't see the pieces!

Luckily we humans have the scientific method that provides the batteries to power four different torches to illuminate the different pieces of the puzzle. There's a torch to see inside nerve cells, another to see what's happening in the brain, one to look in model organisms such as mouse and finally one to look in human patients.

All four torches must be brought together if there is any hope of solving the puzzle.

The Oxford Parkinson's Disease Centre (OPDC) at the University of Oxford recognises the value of this multi-torch approach. The OPDC brings together Consultant Neurologists, mouse geneticists, biologists who are experts in how the basal ganglia works (the part of the brain affected in Parkinson's) and cell biologists to ensure the flow of knowledge from genes to nerve cell to brain to patient is as complete as possible; the intensity of light from four torches is higher than any one torch alone.

From patients...

The first piece of the puzzle that needs to be laid down is an accurate definition of Parkinson's disease. This provides the necessary context for all research and frames the target that a cure needs to aim for. Such a comprehensive definition will also help to identify individuals with Parkinson's before the emergence of symptoms (someone diagnosed today has already lost about 70% of dopamine producing nerve cells in the sustantia nigra). Dr Michelle Hu, a Consultant Neurologist, is leading a major effort to recruit 1000 Parkinson's patients in the Thames valley area (and subjecting them to a wide range of movement, behavioural and cognitive tests) to understand the disease in greater detail. It is hoped that the data generated can also address a crucial question: are the many and highly variable symptoms currently grouped together as Parkinson's disease in fact several diseases? This could prove vital to work out if there is more than one jigsaw puzzle to solve.

A related aim of the study is to find so called biomarkers (i.e. signs of the disease expressed by the body possibly up to 15 years before symptoms emerge). Currently there is no presymptom or diagnostic test for Parkinson's. Dr Hu presented two promising approaches; preliminary data shows that cells in the gut in some Parkinson's sufferers have the same accumulation of protein (called alpha synuclein) that is seen in nerve cells that die in the brain of sufferers. Gut cells are easier to analyse and if the accumulated protein is present in the gut it is likely to also be in the brain where it will eventually cause Parkinson's. Therefore, identifying diseased gut cells before movement symptoms occur will enable earlier intervention to improve quality of life.

A less invasive and potential large scale approach could be to record a person's voice online or over the telephone and a computer program would look for any early signs of tremor in the vocal cords. This could revolutionise and simplify diagnosis.

SEE PART 2 TOMORROW!

Please support research and Dave the worm! http://www.davetheworm.org/

OPDC http://opdc.medsci.ox.ac.uk/